Companies
- Companies
- Company details
Genset
Summary
Genset, a subsidiary of Serono, is a genomics-based biotechnology company committed to generating a pipeline of drug candidates and drug targets for the treatment of central nervous system (CNS) and metabolic diseases.
R&D
To view this information, you must subscribe to Pharmalicensing Intelligence.
Deals
To view this information, you must subscribe to Pharmalicensing Intelligence.
Senior management
To view this information, you must subscribe to Pharmalicensing Intelligence.
Board of directors
To view this information, you must subscribe to Pharmalicensing Intelligence.
Related Reports
Market Research Reports provided by reports.iptechex.com
May 2011 - 25 pages - $250
May 2011 - 25 pages - $250
May 2011 - 25 pages - $125
Apr 2011 - 32 pages - $125
Dec 2010 - 50 pages - $2,500
Feb 2011 - 30 pages - $125
Mar 2011 - 28 pages - $250
Mar 2011 - 36 pages - $250
Jan 2012 - 35 pages - $250
Jan 2012 - 29 pages - $250
Contact details
To view this information, you must subscribe to Pharmalicensing Intelligence.
Head office
Related companies
Related categories
- Industry sector
- Biotechnology / Diagnostic test systems
- Biotechnology / Human therapeutics
- Diagnostic / Test systems
- Drug discovery
- Pharmaceutical / Prescription
- Therapeutic target
- Cardiovascular
- Central Nervous System
- Infectious diseases
- Metabolism
- Metabolism / Obesity
- Metabolism / Diabetes type I
- Oncology
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us